Canagliflozin
Also known as Invokana (us), Sulisent (india)
Canagliflozin is used to: lower blood sugar in people with type 2 diabetes (condition in which blood sugar is too high because the body does not make or use insulin normally).
United States
$573
per month
India
$17
per month
You save
−97%save $556/mo · 97% cheaper
255.8K US scripts/yr$142.3M potential annual savings$146.7M US spend/yr
Drag to rotate · 3D structureC24H25FO5S
SMILES: CC1=C(C=C(C=C1)[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)CC3=CC=C(S3)C4=CC=C(C=C4)F
Compare the price
US price$574per month
India priceNot availableno India data yet
You save—add India price to compare
Based on 30 EAs per month. US $19.12 per unit — India price not available for this variant.
Total over 1 periodIndia price not availableUS total $574
The bigger picture
Canagliflozin is filled about 255.8K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$146.7M
If sourced from India
$4.4M
Potential annual savings
$142.3M
−97%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.